Coronavirus, health, Science

FDA issues full approval for Pfizer’s COVID-19 vaccine

File photo: Chas Hundley

The U.S. Food and Drug Administration (FDA) today announced full approval of the Pfizer-BioNTech COVID-19 vaccine, which now will be marketed as Comirnaty, for the prevention of the coronavirus in individuals 16 years old or older.

The clinical results of the trial showed the vaccine is 91 percent effective in preventing COVID-19.

The Pfizer . . .

You have reached content available exclusively to Gales Creek Journal digital subscribers.

We rely on subscribers to keep the lights on in our independent newsroom. Join us with a digital subscription today.

Click here to subscribe.

Receive a 3-day free trial of unlimited digital access.

Already a subscriber? Login here.

Newsletter

The Miller Team John L Scott Market Center